NCT05414526

Brief Summary

The InterCARE research project proposes to leverage a successful national ART program to develop an effective package to improve the uptake of established effective hypertension and CVD risk factors management interventions among PLWHIV in Botswana and other low- and middle-income countries. Being the first project of its kind in Botswana, if successful, the InterCARE package could be readily rolled out to health facilities nationwide to diagnose, treat, track, and support the estimated 25-30% Batswana with hypertension.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,655

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 10, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

January 31, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

2.5 years

First QC Date

May 18, 2022

Last Update Submit

July 18, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Effectiveness

    Proportion of PLWHIV with diagnosed hypertension receiving anti-hypertensive medication with controlled blood pressure

    Every 6 months for 2 years

  • Implementation

    Proportion of clinic encounters in electronic health records where anti-hypertensive medications are prescribed if indicated, as attained from electronic health records

    Every 6 months for 2 years

Secondary Outcomes (11)

  • Reach

    Every 6 months for 2 years

  • Effectiveness

    Every 12 months for 2 years

  • Adoption

    Every 6 months for 2 years

  • Reach

    Every 6 months for 2 years

  • Maintenance

    Every 6 months for 2 years

  • +6 more secondary outcomes

Study Arms (1)

InterCARE package

EXPERIMENTAL

The type 2 hybrid effectiveness-implementation study will be cluster randomized trial with 1:1 paired randomization (Intervention arm vs Control arm )Using the coin flip randomization method, one clinic will be randomized to the intervention condition, and one to the control condition.

Other: InterCARE package

Interventions

The InterCARE package includes: 1. Healthcare Provider HTN/CVD Curriculum A new HTN curriculum will be developed in collaboration with local stakeholders using KITSO Master trainer program documents (Healthcare provider HIV curriculum), Primary Care Guidelines, HTN/CVD curriculum/protocols trialled in Kweneng District and the CDC Prevention Hypertension Management Curriculum. 2. Adaptation of HIV care EHR for HTN/CVD care EHR modifications will be done to enhance data collection around HTN/CVD care, with input from MoH. 3. Patient and treatment partner sessions Clinic staff will provide in-clinic education and counselling on HTN/CVD to all PLWHIV with a diagnosis of hypertension during their routine HIV clinic visit. All patients will be provided a take-home easy-to-read pamphlet on HTN/CVD risk factor management. All PLWHIV will be asked to bring a treatment partner from their social network at the 2nd study visit so that they can practice role-plays with each other.

InterCARE package

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 20-75 years old
  • Documented HIV-infection on ART
  • Confirmed diagnosis of hypertension or elevated blood pressure \>140/90mmHg versus \>130/80mmHg if they have underlying Diabetes Mellitus or Chronic Kidney Disease
  • Receiving regular care at the selected clinics

You may not qualify if:

  • ● Positive for HIV-related dementia
  • Adults aged 18 years of age or older
  • Selected to be a treatment partner by participant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

14 Infectious Diseases Care centres (IDCCs) nationwide

Gaborone, 0000, Botswana

Location

Phitsane-Molopo IDCC Clinic

Pitsane, Botswana

Location

Tonota IDCC Clinic

Tonota, Botswana

Location

Related Publications (3)

  • Youssouf N, Mogaetsho GE, Moshomo T, Gaolathe T, Ponatshego P, Ramotsababa M, Molefe-Baikai OJ, Dintwa E, Kiki T, Van Pelt AE, Steger-May K, Bogart LM, Jaffar S, Gala P, Wang D, Seipone K, Bennett K, Hurwitz KW, Kebotsamang K, Hirschhorn LR, Mosepele M. Designing an implementation science clinical trial to integrate hypertension and cardiovascular diseases care into existing HIV services package in Botswana (InterCARE). Trials. 2024 Jul 29;25(1):510. doi: 10.1186/s13063-024-08333-0.

  • Moshomo T, Gaolathe T, Ramotsababa M, Molefe-Baikai OJ, Mogaetsho E, Dintwa E, Gala P, Ponatshego P, Bogart LM, Youssouf N, Seipone K, Van Pelt AE, Bennett K, Jaffar S, Ilias M, Tonwe V, Hurwitz KW, Kebotsamang K, Steger-May K, Hirschhorn LR, Mosepele M. Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana. Implement Sci Commun. 2024 Jul 22;5(1):80. doi: 10.1186/s43058-024-00620-w.

  • Gala P, Ponatshego P, Bogart LM, Youssouf N, Ramotsababa M, Van Pelt AE, Moshomo T, Dintwa E, Seipone K, Ilias M, Tonwe V, Gaolathe T, Hirschhorn LR, Mosepele M. A mixed methods approach identifying facilitators and barriers to guide adaptations to InterCARE strategies: an integrated HIV and hypertension care model in Botswana. Implement Sci Commun. 2024 Jun 20;5(1):67. doi: 10.1186/s43058-024-00603-x.

MeSH Terms

Conditions

HIV InfectionsHypertension

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Mosepele Mosepele, MD

    University of Botswana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: InterCARE is the name of the package of implementation strategies proposed by the investigators that are intended to integrate cardiovascular care services into existing HIV care systems in Botswana. The InterCARE package includes 3 main interventions: 1. a tailored inter-professional training curriculum on management of CVD risk and HIV 2. adaptation of the existing electronic health records (PIMS) 3. adoption of a treatment partner support system.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 18, 2022

First Posted

June 10, 2022

Study Start

January 31, 2023

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Data recorded as part of the study will be anonymised and will be deposited in a secured archiving facility at the University of Botswana Health Records Unit. Researchers may request access to data as part of transparency and data sharing however this is strictly upon request and will be governed through the required legal office, with at the least, a Data Sharing Agreement in place. Further details on this can be found in our Data Management plan.

Locations